Rimonabant

Drugs in R & D - Tập 3 - Trang 65-66 - 2012

Tài liệu tham khảo

Barth F, Rinaldi-Carmona M, Arnone M, Heshmati H, Le Fur G. Cannabinoid antagonists: from research tools to potential new drugs. 222nd American Chemical Society National Meeting — Part. 1.: abstr. MEDI 294, 26 Aug 2001. France. [English] Terranova J-P, Storme J-J, Lafon N, et al.. Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. Psychopharmacology. 126: 165–172, Jul 1996. France. [English] Coizet V, Cassel J-C, Kelche C. Effects of the selective CB1 cannabinoid receptor antagonist, SR 141716A, on cognitive performance in intact, brain-damaged and scopolaminetreated rats. Behavioural Pharmacology. 9 (Suppl 1): 25, Aug 1998. France. [English] Heshmati HM, Caplain H, Bellisle F, et al.. SR141716, a selective cannabinoid CB1 receptor antagonist, reduces hunger, caloric intake, and body weight in overweight or obese men. Obesity Research. 9 (Suppl 3): 70, Sep 2001. USA. [English]